chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Flushing, Pharyngeal paraesthesia
Clinical narrative: felt hot; My hands and skin turned red; headache; Felt tickle in throat; slight swelling of tongue; They took by blood pressure and it was high; This is a spontaneous report from a contactable consumer or other non hcp.   A 70-years-old female patient received BNT162B2 (BNT162B2, solution for injection, Batch/Lot Number: EN 6203), via an unspecified route of administration, administered in Arm Left on 10Mar2021 11:00 (at the age of 70-year-old) as dose number unknown, single for covid-19 immunisation.  Medical history included bundle branch block left from an unknown date and unknown if ongoing LBBB , diverticulum from an unknown date and unknown if ongoing. Patient had known allergies. The patient took concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Mar2021 11:00, the patient experienced felt hot, my hands and skin turned red, headache, felt tickle in throat, slight swelling of tongue, they took by blood pressure and it was high.  The patient underwent lab tests and procedures which included blood pressure measurement: high on 10Mar2021. Therapeutic measures were taken as a result of events included IV with benadryl and predinisone pills. The events resulted in emergency room visit. The outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure fluctuation, Erythema, Feeling hot, Headache
Clinical narrative: felt hot; My hands and skin turned red; headache; Felt tickle in throat; slight swelling of tongue; They took by blood pressure and it was high; This is a spontaneous report from a contactable consumer or other non hcp.   A 70-years-old female patient received BNT162B2 (BNT162B2, solution for injection, Batch/Lot Number: EN 6203), via an unspecified route of administration, administered in Arm Left on 10Mar2021 11:00 (at the age of 70-year-old) as dose number unknown, single for covid-19 immunisation.  Medical history included bundle branch block left from an unknown date and unknown if ongoing LBBB , diverticulum from an unknown date and unknown if ongoing. Patient had known allergies. The patient took concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Mar2021 11:00, the patient experienced felt hot, my hands and skin turned red, headache, felt tickle in throat, slight swelling of tongue, they took by blood pressure and it was high.  The patient underwent lab tests and procedures which included blood pressure measurement: high on 10Mar2021. Therapeutic measures were taken as a result of events included IV with benadryl and predinisone pills. The events resulted in emergency room visit. The outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Erythema, Feeling hot, Headache, Hypertension
Clinical narrative: felt hot; My hands and skin turned red; headache; Felt tickle in throat; slight swelling of tongue; They took by blood pressure and it was high; This is a spontaneous report from a contactable consumer or other non hcp.   A 70-years-old female patient received BNT162B2 (BNT162B2, solution for injection, Batch/Lot Number: EN 6203), via an unspecified route of administration, administered in Arm Left on 10Mar2021 11:00 (at the age of 70-year-old) as dose number unknown, single for covid-19 immunisation.  Medical history included bundle branch block left from an unknown date and unknown if ongoing LBBB , diverticulum from an unknown date and unknown if ongoing. Patient had known allergies. The patient took concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Mar2021 11:00, the patient experienced felt hot, my hands and skin turned red, headache, felt tickle in throat, slight swelling of tongue, they took by blood pressure and it was high.  The patient underwent lab tests and procedures which included blood pressure measurement: high on 10Mar2021. Therapeutic measures were taken as a result of events included IV with benadryl and predinisone pills. The events resulted in emergency room visit. The outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swollen tongue, Throat irritation
Clinical narrative: felt hot; My hands and skin turned red; headache; Felt tickle in throat; slight swelling of tongue; They took by blood pressure and it was high; This is a spontaneous report from a contactable consumer or other non hcp.   A 70-years-old female patient received BNT162B2 (BNT162B2, solution for injection, Batch/Lot Number: EN 6203), via an unspecified route of administration, administered in Arm Left on 10Mar2021 11:00 (at the age of 70-year-old) as dose number unknown, single for covid-19 immunisation.  Medical history included bundle branch block left from an unknown date and unknown if ongoing LBBB , diverticulum from an unknown date and unknown if ongoing. Patient had known allergies. The patient took concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Mar2021 11:00, the patient experienced felt hot, my hands and skin turned red, headache, felt tickle in throat, slight swelling of tongue, they took by blood pressure and it was high.  The patient underwent lab tests and procedures which included blood pressure measurement: high on 10Mar2021. Therapeutic measures were taken as a result of events included IV with benadryl and predinisone pills. The events resulted in emergency room visit. The outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus in both ears; This is a spontaneous report from a contactable consumer. A 31-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) via unspecified route of administration in an arm right on 25Jan2021 (at the age of 30-years) as a single dose for COVID-19 immunisation. Medical history was reported as hypertension, bicuspid aortic valve. No allergies to medications, food, or other products was reported. Concomitant medications included Losartan (MANUFACTURER UNKNOWN) and Amlodipine (MANUFACTURER UNKNOWN). The patient had not received any other vaccines within 4 weeks prior to the vaccine. Since the vaccination, the patient had not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. On 28Jan2021, the patient experienced tinnitus in both ears. The first ear (left) began after the first injection and the second ear (right) began after second injection (Tinnitus). The treatment taken for event tinnitus was reported as unknown. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit. The clinical outcome of the event tinnitus was reported as not recovered at the time of this report. No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: throat felt like it was closing up; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN 6203), via an unspecified route of administration in the left arm on 19Mar2021 at 16:00 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Medical history included known allergies with past drugs penicillin and doxycycline. Other medications received within two weeks of vaccination reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that on 19Mar2021 at 16:30, approximately two minutes after the fifteen-minute wait time, her throat felt like it was closing up. It was very scary, but fortunately it lasted for about five minutes or so, and then she was okay and she did not experience any further adverse effects after that. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the event. The clinical outcome of throat tightness was resolved on 19Mar2021.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: sore throat; nasal drip; Chest pain; breathing difficulty; Fever; Extreme exhaustion; headache; body ache; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received first dose of bnt162b2 (BNT162B2, Solution for injection Batch/Lot number was not reported), via an unspecified route of administration on 08Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced extreme exhaustion, headache, body ache, nasal drip, chest pain, breathing difficulty, fever on an unspecified date in Mar2021, sore throat on 15Mar2021. The patient underwent lab tests and procedures which included body temperature (Fever): not more than 100 fahrenheit on Mar2021. Patient got first shot on 08Mar. 12-14 hours later started to have reaction. After a week started to get sore throat. Do not have tonsils. Fever in the eve-nings, not more than 100'F. In the second week saw pcp, he told me to take b12 and zinc along with Cytomel, multivitamins, zyrtec, famotidine, fish oil, calcium citrate. Told me to delay 2nd shot. It was on 22Apr. Patient still have all the symptoms. Patient received treatment with zinc, cytomel, multivitamins, zyrtec, famotidine, fish oil, calcium citrate. Therapeutic measures were taken as a result of extreme exhaustion, headache, body ache, sore throat, nasal drip, chest pain, breathing difficulty, fever. The outcome of events was not recovered.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Pain, Pain in extremity
Clinical narrative: sore throat; nasal drip; Chest pain; breathing difficulty; Fever; Extreme exhaustion; headache; body ache; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received first dose of bnt162b2 (BNT162B2, Solution for injection Batch/Lot number was not reported), via an unspecified route of administration on 08Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced extreme exhaustion, headache, body ache, nasal drip, chest pain, breathing difficulty, fever on an unspecified date in Mar2021, sore throat on 15Mar2021. The patient underwent lab tests and procedures which included body temperature (Fever): not more than 100 fahrenheit on Mar2021. Patient got first shot on 08Mar. 12-14 hours later started to have reaction. After a week started to get sore throat. Do not have tonsils. Fever in the eve-nings, not more than 100'F. In the second week saw pcp, he told me to take b12 and zinc along with Cytomel, multivitamins, zyrtec, famotidine, fish oil, calcium citrate. Told me to delay 2nd shot. It was on 22Apr. Patient still have all the symptoms. Patient received treatment with zinc, cytomel, multivitamins, zyrtec, famotidine, fish oil, calcium citrate. Therapeutic measures were taken as a result of extreme exhaustion, headache, body ache, sore throat, nasal drip, chest pain, breathing difficulty, fever. The outcome of events was not recovered.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chest pain, Dyspnoea, Fatigue, Headache
Clinical narrative: sore throat; nasal drip; Chest pain; breathing difficulty; Fever; Extreme exhaustion; headache; body ache; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received first dose of bnt162b2 (BNT162B2, Solution for injection Batch/Lot number was not reported), via an unspecified route of administration on 08Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced extreme exhaustion, headache, body ache, nasal drip, chest pain, breathing difficulty, fever on an unspecified date in Mar2021, sore throat on 15Mar2021. The patient underwent lab tests and procedures which included body temperature (Fever): not more than 100 fahrenheit on Mar2021. Patient got first shot on 08Mar. 12-14 hours later started to have reaction. After a week started to get sore throat. Do not have tonsils. Fever in the eve-nings, not more than 100'F. In the second week saw pcp, he told me to take b12 and zinc along with Cytomel, multivitamins, zyrtec, famotidine, fish oil, calcium citrate. Told me to delay 2nd shot. It was on 22Apr. Patient still have all the symptoms. Patient received treatment with zinc, cytomel, multivitamins, zyrtec, famotidine, fish oil, calcium citrate. Therapeutic measures were taken as a result of extreme exhaustion, headache, body ache, sore throat, nasal drip, chest pain, breathing difficulty, fever. The outcome of events was not recovered.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Nasal discomfort, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: sore throat; nasal drip; Chest pain; breathing difficulty; Fever; Extreme exhaustion; headache; body ache; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received first dose of bnt162b2 (BNT162B2, Solution for injection Batch/Lot number was not reported), via an unspecified route of administration on 08Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced extreme exhaustion, headache, body ache, nasal drip, chest pain, breathing difficulty, fever on an unspecified date in Mar2021, sore throat on 15Mar2021. The patient underwent lab tests and procedures which included body temperature (Fever): not more than 100 fahrenheit on Mar2021. Patient got first shot on 08Mar. 12-14 hours later started to have reaction. After a week started to get sore throat. Do not have tonsils. Fever in the eve-nings, not more than 100'F. In the second week saw pcp, he told me to take b12 and zinc along with Cytomel, multivitamins, zyrtec, famotidine, fish oil, calcium citrate. Told me to delay 2nd shot. It was on 22Apr. Patient still have all the symptoms. Patient received treatment with zinc, cytomel, multivitamins, zyrtec, famotidine, fish oil, calcium citrate. Therapeutic measures were taken as a result of extreme exhaustion, headache, body ache, sore throat, nasal drip, chest pain, breathing difficulty, fever. The outcome of events was not recovered.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Injection site erythema, Injection site pruritus, Joint swelling, Rash papular
Clinical narrative: Itching at injection site; Red raised hot welt at site; Red raised hot welt at site; Finger joints on left hand are slightly swollen; Finger joints on left hand are sore; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non pregnant female patient received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via unspecified route of administration in the left arm on 16Mar2021(at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) and esomeprazole magnesium (NEXIUM) for unknown indications from unknown date. The Patient did not have any allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021, the patient experienced itching at injection site, red raised hot welt at site which was subsiding over time, welt which was diminished but itches at site one week later and also had finger joints on left hand are sore and slightly swollen. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events vaccination site erythema and vaccination site warmth was resolving and of the vaccination site pruritus, soreness of joint and swollen joint was unknown. No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Itching at injection site; Red raised hot welt at site; Red raised hot welt at site; Finger joints on left hand are slightly swollen; Finger joints on left hand are sore; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non pregnant female patient received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via unspecified route of administration in the left arm on 16Mar2021(at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) and esomeprazole magnesium (NEXIUM) for unknown indications from unknown date. The Patient did not have any allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021, the patient experienced itching at injection site, red raised hot welt at site which was subsiding over time, welt which was diminished but itches at site one week later and also had finger joints on left hand are sore and slightly swollen. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events vaccination site erythema and vaccination site warmth was resolving and of the vaccination site pruritus, soreness of joint and swollen joint was unknown. No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Joint swelling, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Itching at injection site; Red raised hot welt at site; Red raised hot welt at site; Finger joints on left hand are slightly swollen; Finger joints on left hand are sore; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non pregnant female patient received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via unspecified route of administration in the left arm on 16Mar2021(at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) and esomeprazole magnesium (NEXIUM) for unknown indications from unknown date. The Patient did not have any allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021, the patient experienced itching at injection site, red raised hot welt at site which was subsiding over time, welt which was diminished but itches at site one week later and also had finger joints on left hand are sore and slightly swollen. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events vaccination site erythema and vaccination site warmth was resolving and of the vaccination site pruritus, soreness of joint and swollen joint was unknown. No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cheilitis
Clinical narrative: lip sore; lip blisters; It appears to be shingles; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: ER2613), via an unspecified route of administration in the left arm on 18Mar2021 at 11:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medication included birth control pills. The patient was not having any allergies. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient had not been tested for COVID-19 since the vaccination. On 20Mar2021, the patient experienced sore lip and lip blisters and shingles on an unknown date in Mar2021.  The patient had a little sore appear on her bottom lip within 24/36 hours of the vaccine. She got another and another and its now 1 week later and both her top and bottom lip have a line of little sores/blisters that were now starting to scab over that burn and hurt. The patient also reported that it appeared to be shingles which she never had but did have the chicken pox at 15 years old. Therapeutic measure was taken for the event  which was Acyclovir 800 mg every 4 hours for 5 days. The clinical outcome of the events was ongoing at the time of the report.    No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Lip blister, Lip pain
Clinical narrative: lip sore; lip blisters; It appears to be shingles; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: ER2613), via an unspecified route of administration in the left arm on 18Mar2021 at 11:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medication included birth control pills. The patient was not having any allergies. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient had not been tested for COVID-19 since the vaccination. On 20Mar2021, the patient experienced sore lip and lip blisters and shingles on an unknown date in Mar2021.  The patient had a little sore appear on her bottom lip within 24/36 hours of the vaccine. She got another and another and its now 1 week later and both her top and bottom lip have a line of little sores/blisters that were now starting to scab over that burn and hurt. The patient also reported that it appeared to be shingles which she never had but did have the chicken pox at 15 years old. Therapeutic measure was taken for the event  which was Acyclovir 800 mg every 4 hours for 5 days. The clinical outcome of the events was ongoing at the time of the report.    No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node over collar bone; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route of administration in the left arm on 04Mar2021 at 14:15 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and sulpha allergy. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) for unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 12:00, patient experienced swollen lymph node over collar bone. The patient did not receive any treatment for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph node over collar bone was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Headache; Chills; Body ache; Fatigue; This is a spontaneous report from a contactable nurse, the patient. A 69-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in the left arm on 20Mar2021 at 10:45 (at the age of 69-years-old), as single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient no known allergies to medications, food, or other product. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 21Mar2021 at 05:00, the patient experienced headache, chills, body ache and fatigue. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of headache, chills, general body pain and fatigue was recovered on unspecified date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea
Clinical narrative: Headache; Chills; Body ache; Fatigue; This is a spontaneous report from a contactable nurse, the patient. A 69-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in the left arm on 20Mar2021 at 10:45 (at the age of 69-years-old), as single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient no known allergies to medications, food, or other product. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 21Mar2021 at 05:00, the patient experienced headache, chills, body ache and fatigue. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of headache, chills, general body pain and fatigue was recovered on unspecified date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Pain
Clinical narrative: Headache; Chills; Body ache; Fatigue; This is a spontaneous report from a contactable nurse, the patient. A 69-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in the left arm on 20Mar2021 at 10:45 (at the age of 69-years-old), as single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient no known allergies to medications, food, or other product. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 21Mar2021 at 05:00, the patient experienced headache, chills, body ache and fatigue. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of headache, chills, general body pain and fatigue was recovered on unspecified date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Fatigue, Flushing
Clinical narrative: flushed; extremely tired; metallic taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6706) via an unspecified route of administration in the left arm on 24Mar2021 at 11:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included overweight by about 25 pounds. Concomitant medications included echinacea (MANUFACTURER UNKNOWN) and simvastatin (MANUFACTURER UNKNOWN) at 10 mg daily and unspecified multivitamin (MANUFACTURER UNKNOWN), all since unknown dates for unspecified indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received codeine and trimethoprim (+) sulphamethoxazole (BACTRIM) in the past and experienced drug allergy. On 24Mar2021 at 12:00, the patient started to have metallic taste in her mouth. It lasted for 3-4 hours. She also became flushed and extremely tired after about 20 minutes. The flushing lasted about an hour and she was feeling bone-tired even after 24 hours. The adverse events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcomes of the events metallic taste in mouth and flushed were recovered on 24Mar2021 while that of the event tiredness was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chills, Fatigue, Headache, Myalgia
Clinical narrative: chest tightness; muscle soreness; 24 hours of fatigue; headache; chills; fever; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 26Feb2021 at 14:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to potatoes. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Mar2021, the patient experienced 24 hours of fatigue then was okay until 2 weeks after when muscle soreness and chest tightness set in. This was followed by headache, chills and fever which lasted until middle of third week. The symptoms were subsiding at the time of the report. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events 24 hours of fatigue, muscle soreness, chest tightness, headache, chills and fever. The clinical outcomes of the events fatigue, muscle soreness, chest tightness, headache, chills and fever were recovering at the time of the report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: chest tightness; muscle soreness; 24 hours of fatigue; headache; chills; fever; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 26Feb2021 at 14:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to potatoes. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Mar2021, the patient experienced 24 hours of fatigue then was okay until 2 weeks after when muscle soreness and chest tightness set in. This was followed by headache, chills and fever which lasted until middle of third week. The symptoms were subsiding at the time of the report. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events 24 hours of fatigue, muscle soreness, chest tightness, headache, chills and fever. The clinical outcomes of the events fatigue, muscle soreness, chest tightness, headache, chills and fever were recovering at the time of the report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Injection site pain, Pain, Pyrexia
Clinical narrative: Fever; Chills; Weakness; Soreness in shot arm; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration into left arm on 24Mar2021 at 16:15 (at the age of 45-year-old) as single dose for COVID-19 immunisation. The patient did not have any medical history. The patient received birth control (MANUFACTURER UNKNOWN) within two weeks of vaccination. No known allergies were reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient had COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 15:00, the patient experienced fever, chills, weakness and soreness in shot arm. The adverse event did not result in a visit to the doctors or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No treatment was received for the adverse events. The clinical outcome of events fever, chills, weakness and painful arm were not resolved at the time of this report.   No follow-up attempts possible. No further information expected.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Pain in extremity, Pyrexia
Clinical narrative: Fever; Chills; Weakness; Soreness in shot arm; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration into left arm on 24Mar2021 at 16:15 (at the age of 45-year-old) as single dose for COVID-19 immunisation. The patient did not have any medical history. The patient received birth control (MANUFACTURER UNKNOWN) within two weeks of vaccination. No known allergies were reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient had COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 15:00, the patient experienced fever, chills, weakness and soreness in shot arm. The adverse event did not result in a visit to the doctors or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No treatment was received for the adverse events. The clinical outcome of events fever, chills, weakness and painful arm were not resolved at the time of this report.   No follow-up attempts possible. No further information expected.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye irritation, Fatigue, Headache, Oral discomfort, Throat irritation
Clinical narrative: Shake uncontrollably; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the right arm on 22Mar2021 at 11:45 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and psoriasis. The patient did not have any allergies to medications, food, or other products. Concomitant medication included sertraline (MANUFACTURER UNKNOWN) for an unspecified indication from unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021 at 12:00, within 15 minutes of receiving the vaccine the patient began to shake uncontrollably. The patient was taken immediately to the emergency room. The episode lasted for about 4 hours. After 4 days, she had uncontrollable shaking episodes every day since then and it happened several times a day. The patient was treated with unspecified prescription medication. The event result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of uncontrollable shaking episodes was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: Shake uncontrollably; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the right arm on 22Mar2021 at 11:45 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and psoriasis. The patient did not have any allergies to medications, food, or other products. Concomitant medication included sertraline (MANUFACTURER UNKNOWN) for an unspecified indication from unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021 at 12:00, within 15 minutes of receiving the vaccine the patient began to shake uncontrollably. The patient was taken immediately to the emergency room. The episode lasted for about 4 hours. After 4 days, she had uncontrollable shaking episodes every day since then and it happened several times a day. The patient was treated with unspecified prescription medication. The event result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of uncontrollable shaking episodes was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Feeling unwell; Tiredness; Headache; Muscle pain; Joint pain; Nausea; Chills; Shakiness; Fever of 103.6; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration in the right arm on 23Mar2021 at 16:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included reflex sympathetic dystrophy (RSD), gastroparesis, excessive factor 8 disorder, lupus anticoagulant, methicillin-resistant staphylococcus aureus (MRSA) carrier, high blood pressure, hypothyroidism, deep vein thrombosis (DVT), upper body blood clots, diabetes, vitamin d deficiency, non-alcoholic fatty liver disease (NAFLD). The patient received other medications (unspecified) within two weeks of vaccination. The patient had known allergies (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient experienced feeling unwell, tiredness, headache, muscle pain, joint pain, nausea, chills, shakiness and fever of 103.6 (unspecified units) on 25Mar2021 at 06:00. The patient did not receive any treatment for the events. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events feeling unwell, tiredness, headache, muscle pain, joint pain, nausea, chills, shakiness, and fever was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Myalgia, Nausea, Pyrexia, Tremor
Clinical narrative: Feeling unwell; Tiredness; Headache; Muscle pain; Joint pain; Nausea; Chills; Shakiness; Fever of 103.6; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration in the right arm on 23Mar2021 at 16:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included reflex sympathetic dystrophy (RSD), gastroparesis, excessive factor 8 disorder, lupus anticoagulant, methicillin-resistant staphylococcus aureus (MRSA) carrier, high blood pressure, hypothyroidism, deep vein thrombosis (DVT), upper body blood clots, diabetes, vitamin d deficiency, non-alcoholic fatty liver disease (NAFLD). The patient received other medications (unspecified) within two weeks of vaccination. The patient had known allergies (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient experienced feeling unwell, tiredness, headache, muscle pain, joint pain, nausea, chills, shakiness and fever of 103.6 (unspecified units) on 25Mar2021 at 06:00. The patient did not receive any treatment for the events. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events feeling unwell, tiredness, headache, muscle pain, joint pain, nausea, chills, shakiness, and fever was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Feeling unwell; Tiredness; Headache; Muscle pain; Joint pain; Nausea; Chills; Shakiness; Fever of 103.6; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration in the right arm on 23Mar2021 at 16:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included reflex sympathetic dystrophy (RSD), gastroparesis, excessive factor 8 disorder, lupus anticoagulant, methicillin-resistant staphylococcus aureus (MRSA) carrier, high blood pressure, hypothyroidism, deep vein thrombosis (DVT), upper body blood clots, diabetes, vitamin d deficiency, non-alcoholic fatty liver disease (NAFLD). The patient received other medications (unspecified) within two weeks of vaccination. The patient had known allergies (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient experienced feeling unwell, tiredness, headache, muscle pain, joint pain, nausea, chills, shakiness and fever of 103.6 (unspecified units) on 25Mar2021 at 06:00. The patient did not receive any treatment for the events. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events feeling unwell, tiredness, headache, muscle pain, joint pain, nausea, chills, shakiness, and fever was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: After about 10 minutes I started feeling a mild tightening in my throat.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: ER2613) via an unspecified route of administration in the right arm on 26Mar2021 at 10:00 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Medical history included migraines since 1986, high blood pressure since 2015 and thyroid cancer on an unknown date in 2017. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) 100mc per day for thyroid cancer from an unknown date and amlodipine 5 mg per day (MANUFACTURER UNKNOWN) for high blood pressure from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021 at 10:15 the patient felt mild tightening in throat. No other symptoms, no difficulty breathing either. The patient did not receive any treatment for the adverse event. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event throat tightness was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.